MarketCap
Facebook
X
Telegram
Cerner Corporation Revenue | CERN
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.76 B | 5.51 B | 5.69 B | 5.37 B | 5.14 B | 4.43 B | 3.4 B | - | 2.91 B | 2.67 B | 1.85 B | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.76 B | 1.85 B | 4.27 B |
Quarterly Revenue Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.43 B | - | 1.47 B | 1.46 B | 1.39 B | 1.4 B | 1.37 B | 1.33 B | 1.41 B | 1.44 B | 1.43 B | 1.43 B | 1.39 B | 1.37 B | 1.34 B | 1.37 B | 1.29 B | 1.31 B | 1.28 B | 1.29 B | 1.26 B | 1.26 B | 1.18 B | 1.22 B | 1.14 B | 926 M | 1.13 B | 1.13 B | 996 M | - | 840 M | 852 M | 785 M | 795 M | 728 M | 708 M | 680 M | 710 M | 676 M | 637 M | 641 M | 616 M | 572 M | 524 M | 492 M | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.47 B | 492 M | 1.09 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Health information services industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
414 M | - | 0.29 % | $ 206 M |  USA |
 |
OptimizeRx Corporation
OPRX
|
109 M | $ 6.37 | 0.47 % | $ 118 M | USA |
 |
Change Healthcare
CHNG
|
3.48 B | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
347 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
4.58 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
147 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
673 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
668 M | - | - | $ 6.37 B | USA |
 |
So-Young International
SY
|
1.52 B | $ 1.94 | -1.02 % | $ 151 M |  China |
 |
HealthEquity
HQY
|
1.31 B | $ 104.13 | 2.85 % | $ 8.97 B | USA |
 |
iCAD
ICAD
|
19.6 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
185 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
594 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
120 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
1.05 B | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
653 M | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
263 M | - | - | $ 2.33 B | USA |
 |
American Well Corporation
AMWL
|
249 M | $ 10.77 | -3.41 % | $ 173 M | USA |
 |
R1 RCM
RCM
|
1.47 B | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
11.4 M | $ 1.06 | -9.4 % | $ 3.62 M | China |
 |
Signify Health
SGFY
|
184 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
17.9 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
67 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
2.88 M | - | - | $ 7.71 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
300 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
318 M | $ 31.37 | 1.98 % | $ 2.67 B | USA |
 |
Phreesia
PHR
|
481 M | $ 11.14 | 2.67 % | $ 665 M | USA |
 |
GoodRx Holdings
GDRX
|
797 M | $ 3.22 | 3.21 % | $ 1.15 B | USA |
 |
Schrödinger
SDGR
|
256 M | $ 15.12 | -1.11 % | $ 1.11 B | USA |
 |
Omnicell
OMCL
|
1.18 B | $ 41.4 | -3.83 % | $ 1.9 B | USA |
 |
Health Catalyst
HCAT
|
311 M | $ 2.16 | 0.93 % | $ 151 M | USA |
 |
HealthStream
HSTM
|
304 M | $ 29.53 | 2.36 % | $ 886 M | USA |
 |
Evolent Health
EVH
|
469 M | $ 3.3 | -11.76 % | $ 377 M | USA |
 |
Teladoc Health
TDOC
|
2.53 B | $ 9.18 | -1.92 % | $ 1.62 B | USA |
 |
10x Genomics
TXG
|
643 M | $ 46.32 | -1.55 % | $ 5.78 B | USA |
 |
Veeva Systems
VEEV
|
3.2 B | $ 207.91 | 3.33 % | $ 34 B | USA |